Organogenesis Inc., Medline Industries, Inc., 3M are Dominating the U.S. Biofilms Treatment Market in 2019

U.S. Biofilms Treatment Market is expected to grow with the CAGR of 8.0% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access full Report @ https://www.databridgemarketresearch.com/reports/us-biofilms-treatment-market

The U.S. biofilms treatment market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in U.S. biofilms treatment market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

  • In July 2018, 3M introduced an advanced and new Tegaderm antimicrobial wound dressing in order to prevent the microbial attack led to biofilm formation. This product enhancement helped the company to earn more revenue by increasing product sales.

Organogenesis Inc.  is the dominating player in the U.S. biofilms treatment market. The other key players existing in the market are Smith+Nephew, ConvaTec Inc. (a subsidiary of ConvaTec Group PLC), Coloplast Group, B. Braun Melsungen AG (a subsidiary of B. Braun Holding GmbH & Co. KG), Zimmer Biomet, PulseCare Medical, Integra LifeSciences Corporation, HARTMANN USA, Inc. (a subsidiary of Hartmann AG), 3M, Sanara MedTech Inc., Misonix, Kerecis, Next Science Limited, MiMedx, Mölnlycke Health Care AB, and Medline Industries, Inc., among others.

U.S. Biofilms Treatment MarketOrganogenesis Inc.

Organogenesis Inc., headquartered is in Massachusetts, U.S. The company is focuses on providing integrated wound healing products that improve patients’ lives at a reduced cost of healthcare. The company has two business segments including advanced wound care, surgical & sports medicine, in which advanced wound care is the market focussed segment. The company has two product categories which are advanced wound care, surgical & sports medicine, in which advanced wound care is the market focused category.

  • In March 2018, Organogenesis Inc. launched new antimicrobial wound management product PuraPly Antimicrobial (AM) in a small size in order to treat serious and complicated wounds. This product launch helped the company to expand its product portfolio of wound management which led the company to earn more revenue.

The company has wide presence across Europe, North America. The company also has various subsidiary companies such as NuTech Medical (U.K.), NanoMatrix, Inc. (China), Prime Merger Sub, Llc (U.S), Organogenesis Switzerland GmbH (Switzerland).

Medline Industries, Inc.

Medline Industries, Inc. headquartered in Illinois, U.S., founded in 1966. The company focuses on providing best health care solutions at a lower cost in order to achieve better results. The company has wide product portfolio including advanced wound care, anesthesia, apparel, beds & mattresses, central sterile, diagnostics, durable medical equipment (DME), environmental services (EVS), equipment & furnishings, foot & ankle, gloves, incontinence, infection prevention, lab supplies, nursing supplies/patient care, nutrition, office supplies, OR/ surgery, pharmacy, respiratory, skin care, textiles, therapy & rehabilitation, urology & ostomy, vascular access, wound care in which wound care, advanced wound care are the market focused categories. The company has presence across North America, Asia

  • In April 2020, Medline Industries, Inc. went under partnership with BandGrip for advancement of surgical wound care solutions involving wound dressings and debridement solutions. This partnership helped the company to promote its product portfolio of wound care treatment which enhanced the company’s revenue.

3M

3M headquartered in Minnesota, U.S. was founded in 1902. The company is engaged in manufacturing of products using advanced science in order to improve daily lives of people. The company operates its business through multiple business segments which are safety and industrial business, transportation and electronics business, health care business, consumer business in which health care business is the market focused segment. The company is engaged in providing wide range of product categories such as automotive, commercial solutions, design & construction, electronics, energy, government, healthcare, manufacturing, mining, oil & gas, safety, transportation in which healthcare is the market focused product categories.

  • In February 2017, 3M enhanced its Cavilon Advanced Skin Protectant solutions used to control the microbial attacks, and hence ensures rapid wound healing. This product enhancement helped the company to promote its product portfolio.

The company is present in Americas, Europe, Middle East & Africa, Asia-Pacific. The company has several owned subsidiaries involving 3M Unitek Corporation (U.S), 3M Australia Pty. Ltd (Australia), 3M Precision Grinding GmbH (Austria), 3M International Trading (Shanghai) Co., Ltd (China), 3M Deutschland GmbH (Germany) among others.